F9H4cetuximabnecitumumabB16F10protease inhibitorslung cancer
…able engagement by tumor cell-opsonizing antibodies. Therefore, F9H4 represents a new opportunity in cancer immunotherapy research.E…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: necitumumab ×
necitumumab
This drug is selected. Its supporting articles are shown below.